Financials Asia Medical and Agricultural Laboratory and Research Center
Equities
AMARC
THB017010000
Business Support Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 THB | +0.73% | -.--% | +0.73% |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 1,168 | 575.4 | 579.6 | - | - |
Enterprise Value (EV) 1 | 1,168 | 575.4 | 579.6 | 579.6 | 579.6 |
P/E ratio | 69.5 x | 68.5 x | 27.6 x | 17.3 x | 13.8 x |
Yield | 3.6% | - | 1.45% | 2.9% | 3.62% |
Capitalization / Revenue | 4.44 x | - | 1.77 x | 1.55 x | 1.38 x |
EV / Revenue | 4.44 x | - | 1.77 x | 1.55 x | 1.38 x |
EV / EBITDA | 20.3 x | - | 9.2 x | 7.16 x | 6.3 x |
EV / FCF | 3,56,54,467 x | - | - | - | - |
FCF Yield | 0% | - | - | - | - |
Price to Book | 2.13 x | - | 1.1 x | 1.07 x | 1.03 x |
Nbr of stocks (in thousands) | 4,20,000 | 4,20,000 | 4,20,000 | - | - |
Reference price 2 | 2.780 | 1.370 | 1.380 | 1.380 | 1.380 |
Announcement Date | 15/02/23 | 15/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | 263.2 | - | 327 | 375 | 419 |
EBITDA 1 | - | 57.62 | - | 63 | 81 | 92 |
EBIT | - | 24.12 | - | - | - | - |
Operating Margin | - | 9.16% | - | - | - | - |
Earnings before Tax (EBT) | - | 17.94 | - | - | - | - |
Net income 1 | 24.86 | 14.52 | 9.644 | 20 | 34 | 42 |
Net margin | - | 5.51% | - | 6.12% | 9.07% | 10.02% |
EPS 2 | 0.0800 | 0.0400 | 0.0200 | 0.0500 | 0.0800 | 0.1000 |
Free Cash Flow | - | 32.75 | - | - | - | - |
FCF margin | - | 12.44% | - | - | - | - |
FCF Conversion (EBITDA) | - | 56.83% | - | - | - | - |
FCF Conversion (Net income) | - | 225.6% | - | - | - | - |
Dividend per Share 2 | - | 0.1000 | - | 0.0200 | 0.0400 | 0.0500 |
Announcement Date | 25/03/22 | 15/02/23 | 15/02/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | 32.7 | - | - | - | - |
ROE (net income / shareholders' equity) | - | 3.82% | - | 3.88% | 6.33% | 7.63% |
ROA (Net income/ Total Assets) | - | 2.53% | - | - | - | - |
Assets 1 | - | 573.7 | - | - | - | - |
Book Value Per Share 2 | - | 1.300 | - | 1.250 | 1.290 | 1.340 |
Cash Flow per Share | - | - | - | - | - | - |
Capex | - | 20.8 | - | - | - | - |
Capex / Sales | - | 7.89% | - | - | - | - |
Announcement Date | 25/03/22 | 15/02/23 | 15/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.73% | 1.57Cr | |
+15.80% | 1.76TCr | |
-.--% | 771.41Cr | |
-19.65% | 263.89Cr | |
-12.60% | 267.33Cr | |
-26.54% | 185.86Cr | |
-10.33% | 106.91Cr | |
-8.09% | 105.34Cr | |
+6.12% | 88Cr | |
-18.81% | 76Cr |
- Stock Market
- Equities
- AMARC Stock
- Financials Asia Medical and Agricultural Laboratory and Research Center